Search

everythinglearnresearchcommunity

for

Search:↓

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Testosterone may influence COVID-19 severity and outcomes.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

There's no significant genetic link between male pattern baldness and COVID-19.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Possible link between androgens and COVID-19 severity; more research needed.

Hair loss doesn't affect COVID-19 severity.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Some alopecia treatments might help treat COVID-19, but more research is needed.